These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2972249)

  • 1. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1988 Aug; 24(2):185-91. PubMed ID: 2972249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
    Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
    N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.
    Takeuchi T; Rudd CE; Schlossman SF; Morimoto C
    Eur J Immunol; 1987 Jan; 17(1):97-103. PubMed ID: 2949986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells.
    Berd D; Mastrangelo MJ
    Cancer Res; 1988 Mar; 48(6):1671-5. PubMed ID: 2830969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.
    Kotani H; Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    Clin Exp Immunol; 1984 May; 56(2):390-8. PubMed ID: 6234113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal regulation of in vitro IgG production in multiple sclerosis.
    Kelly RE; Ellison GW; Myers LW; Goymerac V; Larrick SB; Kelley CC
    Ann Neurol; 1981 Mar; 9(3):267-72. PubMed ID: 6452852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of antibody secreting cells generated in the autologous mixed leukocyte reaction in man.
    Gatenby PA; Engleman EG
    Behring Inst Mitt; 1983 May; (72):143-52. PubMed ID: 6152687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosis.
    Cafaro A; Spadaro M; Pandolfi F; Tilia G; Scarselli E; Liberati F; Aiuti F
    Riv Neurol; 1987; 57(3):159-62. PubMed ID: 2960006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis.
    Trotter JL; Clifford DB; McInnis JE; Griffeth RC; Bruns KA; Perlmutter MS; Anderson CB; Collins KG; Banks G; Hicks BC
    Ann Neurol; 1989 Feb; 25(2):172-8. PubMed ID: 2521993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of immunoregulatory function with cell phenotype in cord blood lymphocytes.
    Kingsley G; Pitzalis C; Waugh AP; Panayi GS
    Clin Exp Immunol; 1988 Jul; 73(1):40-5. PubMed ID: 2971486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of functional suppression is linked to decreases in circulating suppressor-inducer (CD4+ 2H4+) T cells in multiple sclerosis.
    Chofflon M; Weiner HL; Hafler DA
    Ann N Y Acad Sci; 1988; 540():330-2. PubMed ID: 2905122
    [No Abstract]   [Full Text] [Related]  

  • 15. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
    Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
    J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation and characterization of the human helper inducer T cell subset.
    Morimoto C; Letvin NL; Boyd AW; Hagan M; Brown HM; Kornacki MM; Schlossman SF
    J Immunol; 1985 Jun; 134(6):3762-9. PubMed ID: 3157750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isolation and characterization of the human suppressor inducer T cell subset.
    Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
    J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta augments suppressor cell function in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    Ann Neurol; 1990 Feb; 27(2):207-10. PubMed ID: 2138445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated suppressor cell dysfunction in progressive multiple sclerosis.
    Antel JP; Bania MB; Reder A; Cashman N
    J Immunol; 1986 Jul; 137(1):137-41. PubMed ID: 2940299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.